HETEROCYCLIC COMPOUND AND MEDICINAL APPLICATION THEREOF

WIPO Patent Application WO2007058392

A9

It is intended to provide a novel heterocyclic compound having an HCV entry inhibition activity and a medicinal application thereof. The invention relates to the use of the heterocyclic compound represented by the general formula [1]: [wherein Q₁ represents N= or the like, Q₂ represents N or the like, Q₃ represents N= or the like, Q₄ represents N or the like, Q₅ represents N or the like, R¹ represents a hydrogen atom or the like, R² represents a hydrogen atom or the like, the ring A represents a monocyclic aryl group which may have a substituent or the like and the ring B represents a monocyclic aryl group which may have a substituent or the like], a pharmaceutically acceptable salt thereof for the production of a therapeutic agent for hepatitis C and so on.

UENO HIROSHI (JP)
SHIMADA TAKASHI (JP)
AOYAGI KOUICHI (JP)
KATOH SUSUMU (JP)
SHINKAI HISASHI (JP)
MOTOMURA TAKAHISA (JP)
KOMODA YASUMASA (JP)
OTSUBAKI TOMOKO (JP)
SOEJIMA YUKI (JP)
KAWAHARA IICHIRO (JP)

PCT/JP2006/323637

July 05, 2007

November 21, 2006

Click for automatic bibliography generation  

JAPAN TOBACCO INC (JP)
UENO HIROSHI (JP)
SHIMADA TAKASHI (JP)
AOYAGI KOUICHI (JP)
KATOH SUSUMU (JP)
SHINKAI HISASHI (JP)
MOTOMURA TAKAHISA (JP)
KOMODA YASUMASA (JP)
OTSUBAKI TOMOKO (JP)
SOEJIMA YUKI (JP)
KAWAHARA IICHIRO (JP)

C07D237/26; A61K31/502; A61K31/5025; A61K31/55; A61K38/21; A61K45/00; A61P1/16; A61P31/14; C07D401/14; C07D403/10; C07D403/12; C07D405/14; C07D409/04; C07D409/10; C07D409/14; C07D413/10; C07D417/10; C07D471/04; C07D487/04; C07D491/048; C07D495/04

View/Download PDF      PDF Help

Previous Patent: PIPE ULTRASONIC FLAW DETECTING APPARATUS AND ULTRASONIC FLAW DETECTING METHOD

Next Patent: SYSTEM AND METHOD FOR NETWORK -BASED REMOTE TEXT SERVICE